Overview and Scope
A drug-eluting stent (DES) is a medical device used in the treatment of coronary artery disease (CAD). It is a small, mesh-like tube typically made of metal that is inserted into narrowed or blocked coronary arteries during a procedure called percutaneous coronary intervention (PCI) or angioplasty.
Sizing and Forecast
The drug eluting stent market size has grown strongly in recent years. It will grow from $7.05 billion in 2023 to $7.63 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to the need for improved treatment options, clinical evidence, regulatory approval, healthcare economics, and guidelines and recommendations.
The drug eluting stent market size is expected to see strong growth in the next few years. It will grow to $10.52 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to an aging population and chronic disease burden, the expansion of indications, healthcare reimbursement policies, global market expansion, and patient-centered care. Major trends in the forecast period include personalized medicine, minimally invasive techniques, emerging healthcare technologies, and next-generation drug formulations.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report
Segmentation & Regional Insights
The drug eluting stent market covered in this report is segmented –
1) By Product: Polymer-Based, Polymer-Free
2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs
3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds
4) By Application: Coronary Diseases, Peripheral Vascular Diseases
4) By End-User: Hospitals, Specialty Clinics
North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp
Major Driver Impacting Market Growth
The rising burden of coronary heart disease is expected to propel the growth of the drug-eluting stent market going forward. Coronary heart disease (CHD) is a condition where the coronary arteries become narrowed or blocked due to plaque buildup, potentially leading to severe complications such as a heart attack or chest pain. Coronary heart disease is increasing due to sedentary lifestyles, poor diets, aging populations, and heightened awareness. Drug-eluting stents (DES) benefit coronary heart disease by effectively opening narrowed or blocked coronary arteries and releasing medication that helps prevent re-narrowing (restenosis) of the artery. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a US-based governmental organization, the percentage of coronary heart disease in adults aged 18 and over in 2020 was 4.6%, which increased to 4.9% in 2022. The rising burden of coronary heart disease is expected to propel the growth of the drug-eluting stench market.
Key Industry Players
Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.
The drug eluting stent market report table of contents includes:
1. Executive Summary
2. Drug Eluting Stent Market Characteristics
3. Drug Eluting Stent Market Trends And Strategies
4. Drug Eluting Stent Market - Macro Economic Scenario
5. Global Drug Eluting Stent Market Size and Growth
.
.
.
31. Global Drug Eluting Stent Market Competitive Benchmarking
32. Global Drug Eluting Stent Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Drug Eluting Stent Market
34. Drug Eluting Stent Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report
https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
01 Oct 2018 – The Drug Eluting Stent Market is projected to register a higher CAGR during the forecast period. Adoption of minimally invasive techniques may augment the market demand for drug eluting stents.
Market challenges such as declining prices and side effects pertaining to the use of drug eluting stents might impede the market growth. Based on polymer coating, the drug eluting stents market comprises non-biodegradable polymer-based and biodegradable polymer based.
Geographical segmentation for drug eluting stent market includes North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. The market is driven by stringent norms and regulations along with favorable reimbursement coverage.
The Drug Eluting Stent Market is projected to register a higher CAGR during the forecast period.
Adoption of minimally invasive techniques may augment the market demand for drug eluting stents.Increase in geriatric population and shift from angioplasty to DES are likely to propel the market growth during the forecast period.
Market challenges such as declining prices and side effects pertaining to the use of drug eluting stents might impede the market growth.
Based on polymer coating, the drug eluting stents market comprises non-biodegradable polymer-based and biodegradable polymer based.
Based on polymer free coatings, the drug eluting stent industry includes nanoporous surface, slotted tubular surface, micro porous surface and microstructures surface.Download Sample Report @ https://www.millioninsights.com/industry-reports/drug-eluting-stent-market/request-sampleBy application, the market segmentation includes coronary artery disease and peripheral artery disease.
Geographical segmentation for drug eluting stent market includes North America, Latin America, Europe, Asia-Pacific, Middle East and Africa.
San Francisco, 2 June 2020 — “Drug Eluting Stent Market Analysis By Regions (North America, Europe, Asia-Pacific, Latin America and Africa), Product, By Application And Segment Forecasts To 2025” Global Drug Eluting Stent Market is projected to register a higher CAGR during the forecast period.
The drug eluting stent market is highly driven by change in consumers’ lifestyles, heavy consumption of junk food, and prevalence of atherosclerosis in geriatric population.
Adoption of minimally invasive techniques may augment the market demand for drug eluting stents.
Geographical segmentation for drug eluting stent market includes North America, Latin America, Europe, Asia-Pacific, Middle East and Africa.
The market is driven by stringent norms and regulations along with favorable reimbursement coverage.
Asia-Pacific’s market is anticipated to register a higher market growth in the forecast period owing to rise in patients’ awareness pertaining to commercial availability of products, government funding and constant R Improvements in healthcare infrastructure and increase in healthcare spending is likely to propel the market growth APAC sector.
